A prospective observational study of the mental disorder prevalence in patients with non-cardioembolic ischemic stroke - Effect of antiplatelet agents and serum lipid profile for mental function -

A prospective observational study of the mental disorder prevalence in patients with non-cardioembolic ischemic stroke - Effect of antiplatelet agents and serum lipid profile for mental function - - A prospective observational study of the mental disorder prevalence in patients with non-cardioembolic ischemic stroke - Effect of antiplatelet agents and serum lipid profile for mental function -

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013008

Enrollment

120

Registered

2014-01-30

Start date

2013-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-cardioembolic ischemic stroke patients who started treatment within 7 days after the onset

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who were aged 20 years or more. 2) Patients who walk independently before stroke onset (modified Rankin Scale 0-2). 3) Patient who were given their informed consent and agreed to participate with willingness.

Exclusion criteria

Exclusion criteria: 1) Patients who were diagnosed with cardioembolic infarction. 2) Patients suffered known malignancy. 3) Patients who have history of depression treatment. 4) Patients whom the principal investigator regarded as unsuitable for this study.

Design outcomes

Primary

Measure	Time frame
Prevalence of patients with mental disorder by SDS, MMSE, and apathy scale at 12 months.	—

Secondary

Measure	Time frame
1) Correlation of mental disorder and serum lipid profile. 2) Correlation of mental disorder and antiplatelet agents. 3) Correlation of mental disorder and other observations. 4) modified Rankin Score at 12 months. 5) Incidence of stroke and TIA at 12 months. 6) Incidence of all vascular events at 12 months (Stroke, MI, PAD, etc).	—

Countries

Japan

Contacts

Public ContactHisanori Kowa

Tottori University Hospital Division of Neurology

norkowa@med.tottori-u.ac.jp0859-38-6757

Outcome results